- Home
- KROS vs BYRN Comparison
KROS vs BYRN Comparison
Compare KROS & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- BYRN
- Stock Information
- Founded
- KROS 2015
- BYRN 2005
- Country
- KROS United States
- BYRN United States
- Employees
- KROS N/A
- BYRN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- BYRN Industrial Machinery/Components
- Sector
- KROS Health Care
- BYRN Miscellaneous
- Exchange
- KROS Nasdaq
- BYRN Nasdaq
- Market Cap
- KROS 565.0M
- BYRN 530.6M
- IPO Year
- KROS 2020
- BYRN N/A
- Fundamental
- Price
- KROS $15.22
- BYRN $19.96
- Analyst Decision
- KROS Buy
- BYRN Strong Buy
- Analyst Count
- KROS 14
- BYRN 2
- Target Price
- KROS $20.56
- BYRN $41.50
- AVG Volume (30 Days)
- KROS 1.1M
- BYRN 662.2K
- Earning Date
- KROS 11-06-2025
- BYRN 10-09-2025
- Dividend Yield
- KROS N/A
- BYRN N/A
- EPS Growth
- KROS N/A
- BYRN 543.53
- EPS
- KROS 0.47
- BYRN 0.66
- Revenue
- KROS $232,844,000.00
- BYRN $110,853,000.00
- Revenue This Year
- KROS $6,657.47
- BYRN $39.83
- Revenue Next Year
- KROS N/A
- BYRN $20.47
- P/E Ratio
- KROS $32.70
- BYRN $30.30
- Revenue Growth
- KROS 85820.30
- BYRN 50.99
- 52 Week Low
- KROS $9.12
- BYRN $13.68
- 52 Week High
- KROS $72.37
- BYRN $34.78
- Technical
- Relative Strength Index (RSI)
- KROS 49.86
- BYRN 42.38
- Support Level
- KROS $14.77
- BYRN $19.73
- Resistance Level
- KROS $15.30
- BYRN $21.97
- Average True Range (ATR)
- KROS 0.65
- BYRN 1.11
- MACD
- KROS 0.02
- BYRN -0.27
- Stochastic Oscillator
- KROS 75.17
- BYRN 8.39
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.